Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2)
ClinicalTrials.gov Identifier: NCT04915300
Recruitment Status: Not yet recruiting
Last Update Posted: April 18, 2023
https://clinicaltrials.gov/ct2/show/NCT04915300
Sponsors and Collaborators
Laval University
Canadian Institutes of Health Research (CIHR)
Resverlogix Corp
Koo